During the past decade, Hospital General Universitario Morales Meseguer conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 30 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 19 clinical trials were completed. i.e. 41.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Universitario Morales Meseguer" #1 sponsor was "PETHEMA Foundation" with 48 trials, followed by "Spanish Breast Cancer Research Group" with 11 trials sponsored, "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 10 trials sponsored, "Celgene" with 8 trials sponsored and "Gilead Sciences" with 8 trials sponsored. Other sponsors include 113 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario Morales Meseguer" #1 collaborator was "Hoffmann-La Roche" with 7 trials as a collaborator, "Celgene" with 5 trials as a collaborator, "Amgen" with 4 trials as a collaborator, "Apices Soluciones S.L." with 4 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 114 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Universitario Morales Meseguer" are "Multiple Myeloma" (23 trials), "Acute Lymphoblastic Leukemia" (10 trials), "Breast Cancer" (9 trials), "Advanced Prostate Cancer" (4 trials) and "Cardiovascular Disease" (4 trials). Many other conditions were trialed in "Hospital General Universitario Morales Meseguer" in a lesser frequency.

Most popular intervention types in "Hospital General Universitario Morales Meseguer" are "Drug" (155 trials), "Other" (15 trials), "Procedure" (12 trials), "Biological" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Dexamethasone" (21 trials), "Lenalidomide" (11 trials), "Bortezomib" (10 trials) and "Cyclophosphamide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Universitario Morales Meseguer" are 168 trials for "All" genders, 22 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General Universitario Morales Meseguer". 1 are not yet recruiting, 38 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 101 completed trials in Hospital General Universitario Morales Meseguer, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Universitario Morales Meseguer, 11 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 2 trials that are defined as “Not Applicable".